rs139407231

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_025009.5(CEP135):​c.2065A>G​(p.Ile689Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000422 in 1,614,210 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

CEP135
NM_025009.5 missense

Scores

1
18

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.882

Publications

4 publications found
Variant links:
Genes affected
CEP135 (HGNC:29086): (centrosomal protein 135) This gene encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in this gene are associated with autosomal recessive primary microcephaly-8. [provided by RefSeq, Jun 2012]
CEP135 Gene-Disease associations (from GenCC):
  • microcephaly 8, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0049135685).
BP6
Variant 4-55999357-A-G is Benign according to our data. Variant chr4-55999357-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 434722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00232 (353/152376) while in subpopulation AFR AF = 0.00774 (322/41592). AF 95% confidence interval is 0.00705. There are 1 homozygotes in GnomAd4. There are 176 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP135NM_025009.5 linkc.2065A>G p.Ile689Val missense_variant Exon 16 of 26 ENST00000257287.5 NP_079285.2
CEP135XM_006714055.4 linkc.2032A>G p.Ile678Val missense_variant Exon 16 of 26 XP_006714118.1
CEP135XM_005265788.5 linkc.994A>G p.Ile332Val missense_variant Exon 9 of 19 XP_005265845.1
CEP135XM_011534412.2 linkc.535A>G p.Ile179Val missense_variant Exon 6 of 16 XP_011532714.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP135ENST00000257287.5 linkc.2065A>G p.Ile689Val missense_variant Exon 16 of 26 1 NM_025009.5 ENSP00000257287.3
CEP135ENST00000506202.1 linkn.2015A>G non_coding_transcript_exon_variant Exon 9 of 19 1
CEP135ENST00000706801.1 linkn.57A>G non_coding_transcript_exon_variant Exon 1 of 10

Frequencies

GnomAD3 genomes
AF:
0.00226
AC:
344
AN:
152258
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00755
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000661
AC:
166
AN:
251252
AF XY:
0.000471
show subpopulations
Gnomad AFR exome
AF:
0.00920
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000225
AC:
329
AN:
1461834
Hom.:
0
Cov.:
32
AF XY:
0.000183
AC XY:
133
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.00800
AC:
268
AN:
33480
American (AMR)
AF:
0.000559
AC:
25
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111982
Other (OTH)
AF:
0.000480
AC:
29
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00232
AC:
353
AN:
152376
Hom.:
1
Cov.:
32
AF XY:
0.00236
AC XY:
176
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00774
AC:
322
AN:
41592
American (AMR)
AF:
0.00157
AC:
24
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68044
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000760
Hom.:
2
Bravo
AF:
0.00242
ESP6500AA
AF:
0.00749
AC:
33
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000799
AC:
97
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEP135: BP4 -

not specified Benign:1
Apr 15, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CEP135-related disorder Benign:1
May 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.018
DANN
Benign
0.22
DEOGEN2
Benign
0.0050
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.69
T
M_CAP
Uncertain
0.098
D
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.14
N
PhyloP100
-0.88
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.085
Sift
Benign
0.86
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.082
MVP
0.14
MPC
0.051
ClinPred
0.0043
T
GERP RS
-5.5
Varity_R
0.020
gMVP
0.037
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139407231; hg19: chr4-56865523; API